AI Maverick Intel Inc. (OTC: AIMV) announced the appointment of Dr. Wayne Young, BSc, DDS, to its Board of Directors on Tuesday, a move that coincides with the company's efforts to acquire 100% of the issued and outstanding shares of HEAL Access Canada Inc. from HEAL Group Holdings Inc. The acquisition, subject to certain closing conditions, is intended to establish HEAL Access as the foundation of AI Maverick Intel's operating strategy in artificial intelligence-enabled healthcare.
Dr. Young brings more than three decades of experience spanning healthcare, clinical practice, business, and leadership. His appointment adds significant medical and operational expertise to the board as the company pivots toward integrating AI technologies into healthcare markets. The company believes that HEAL Access will serve as the initial platform for this strategy, with plans to evaluate complementary opportunities that leverage AI to address real-world healthcare needs.
In a separate development, AI Maverick Intel also announced a settlement with Stronghold Media Group Corp. Under the agreement, the parties mutually rescinded their August 2024 transaction and resolved their respective obligations related to it. As part of the settlement, the associated intellectual property was reassigned to Stronghold Group. This resolution clears the way for AI Maverick Intel to focus on its new strategic direction without lingering legal or financial entanglements from the prior deal.
As part of its corporate transition, AI Maverick Intel plans to complete a corporate name change. The company expects to announce its new name and identity following the completion of necessary corporate and regulatory processes. This rebranding is likely intended to reflect the company's renewed focus on AI-driven healthcare solutions and to distance itself from previous operations.
The appointment of Dr. Young and the progress on the HEAL Access acquisition are significant for investors and industry observers. They signal a clear strategic shift for AI Maverick Intel, which is traded on OTC Markets under the symbol AIMV. The company aims to build and grow operating businesses that apply artificial intelligence and data technologies to healthcare and related markets. If successful, this pivot could position AI Maverick Intel in the rapidly growing field of AI-enabled healthcare, potentially driving long-term value. However, the acquisition remains subject to closing conditions, and the name change is pending regulatory approval, so uncertainties persist.
For more details, the full press release can be viewed at https://nnw.fm/dtv7m. The latest news and updates relating to AIMV are available in the company's newsroom at http://nnw.fm/AIMV.
NetworkNewsWire, a specialized communications platform focused on financial news and content distribution, published the announcement. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution, and a full array of tailored corporate communications solutions. For full terms of use and disclaimers, visit https://www.NetworkNewsWire.com/Disclaimer.
